series-b
Stage
2
Investors
About
Stromedix is a biotech company developing a novel therapeutic approach for the treatment of chronic kidney disease (CKD). They are currently in preclinical development.
Explore Stromedix's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.